Cambridge Investment Research Advisors’s Innovator US Equity 5 to 15 Buffer ETF Quarterly EALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
53,671
+12,868
+32% +$454K ﹤0.01% 1597
2026
Q1
$1.37M Buy
40,803
+15,632
+62% +$551K ﹤0.01% 1901
2025
Q4
$888K Buy
25,171
+87
+0.3% +$3.04K ﹤0.01% 2194
2025
Q3
$867K Buy
25,084
+11,165
+80% +$375K ﹤0.01% 2163
2025
Q2
$453K Buy
+13,919
New +$435K ﹤0.01% 2633
2024
Q4
Sell
-15,442
Closed -$489K 3504
2024
Q3
$489K Sell
15,442
-37,867
-71% -$1.15M ﹤0.01% 2437
2024
Q2
$1.6M Buy
53,309
+18,216
+52% +$529K 0.01% 1443
2024
Q1
$1.02M Buy
+35,093
New +$989K ﹤0.01% 1722

Other funds holding EALT

Cambridge Investment Research Advisors's EALT Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Innovator US Equity 5 to 15 Buffer ETF Quarterly (EALT) stake by 32% in Q2 2026, buying an estimated $454K and bringing the position to 53,671 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Cambridge Investment Research Advisors first reported a position in EALT in Q1 2024 and has held it in 8 quarters since. 17 funds tracked by Wall St. Rank hold EALT as of Q2 2026.

  • Cambridge Investment Research Advisors held 53,671 shares of Innovator US Equity 5 to 15 Buffer ETF Quarterly worth $1.93M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 12,868 Innovator US Equity 5 to 15 Buffer ETF Quarterly shares in Q2 2026, an estimated $454K.
  • Innovator US Equity 5 to 15 Buffer ETF Quarterly made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1597 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator US Equity 5 to 15 Buffer ETF Quarterly in Q1 2024 and has held it in 8 quarters since.
  • 17 funds tracked by Wall St. Rank held Innovator US Equity 5 to 15 Buffer ETF Quarterly as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.